AM
Aby J. Mathew
EVP & Chief Scientific Officer

Aby J. Mathew insider trades: Biolife Solutions (BLFS) stock buys and sales

EVP & Chief Scientific Officer, Biolife Solutions Last trade Mar 3, 2026 141 Form 4 filings
$51K
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
103
Open-market trades
since 2014
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Aby reports to the SEC

Open-market buys and sales

103 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 3, 2026BLFS↓ Sell$11K
Jan 6, 2026BLFS↓ Sell$10K
Dec 9, 2025BLFS↓ Sell$16K
Nov 25, 2025BLFS↓ Sell$14K
Oct 9, 2025BLFS↓ Sell$14K
Sep 11, 2025BLFS↓ Sell$17K
Aug 26, 2025BLFS↓ Sell$14K
Jul 7, 2025BLFS↓ Sell$12K
Jun 10, 2025BLFS↓ Sell$15K
May 28, 2025BLFS↓ Sell$12K
Apr 9, 2025BLFS↓ Sell$11K
Apr 1, 2025BLFS↓ Sell$240K
Mar 11, 2025BLFS↓ Sell$40K
Mar 3, 2025BLFS↓ Sell$11K
Feb 12, 2025BLFS↓ Sell$2K
Jan 6, 2025BLFS↓ Sell$11K
Dec 17, 2024BLFS↓ Sell$566K
Nov 26, 2024BLFS↓ Sell$14K
Nov 18, 2024BLFS↓ Sell$882K
Nov 12, 2024BLFS↓ Sell10b5-1$3K
Oct 30, 2024BLFS↓ Sell$13K
Oct 16, 2024BLFS↓ Sell$465K
Sep 19, 2024BLFS↓ Sell$494K
Sep 16, 2024BLFS↓ Sell$18K
May 29, 2024BLFS↓ Sell$11K
May 17, 2024BLFS↓ Sell$2K
Apr 18, 2024BLFS↓ Sell$9K
Mar 27, 2024BLFS↓ Sell$8K
Mar 12, 2024BLFS↓ Sell$114K
Feb 21, 2024BLFS↓ Sell$2K
Jan 19, 2024BLFS↓ Sell$24K
Jan 2, 2024BLFS↓ Sell$12K
Dec 1, 2023BLFS↓ Sell$7K
Nov 13, 2023BLFS↓ Sell$1K
Sep 28, 2023BLFS↓ Sell$9K
Aug 25, 2023BLFS↓ Sell$6K
Aug 14, 2023BLFS↓ Sell$2K
Jul 20, 2023BLFS↓ Sell$405K
Jun 27, 2023BLFS↓ Sell$16K
Jun 22, 2023BLFS↓ Sell$463K
May 31, 2023BLFS↓ Sell$12K
May 25, 2023BLFS↓ Sell$445K
May 15, 2023BLFS↓ Sell$2K
Apr 20, 2023BLFS↓ Sell$387K
Apr 6, 2023BLFS↓ Sell$42K
Mar 29, 2023BLFS↓ Sell$15K
Mar 23, 2023BLFS↓ Sell$432K
Mar 7, 2023BLFS↓ Sell$10K
Mar 1, 2023BLFS↓ Sell$47K
Feb 9, 2023BLFS↓ Sell$2K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BLFS insiders

Open-market trades in the last 12 months

About Aby J. Mathew's insider trades

Aby J. Mathew is EVP & Chief Scientific Officer at Biolife Solutions (BLFS). Since May 14, 2014, Aby has reported 1 open-market purchase worth $20K and 102 sales worth $20.9M on SEC Form 4. In the last 12 months: 4 sales ($51K).

1 sale (0% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include option exercises (35 filings), grants and awards (32 filings), shares withheld for taxes (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BLFS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.